Enlivex Therapeutics Ltd. Gains 37.85%

Enlivex Therapeutics Ltd. (ENLV:NASDAQ) rocketted at $11.4, representing a gain of 37.8%. On Wed 02 Dec 20, ENLV:NASDAQ touched a New 2-Week Intraday Low of $8.08. The stock appeared on our News Catalysts scanner on Thu 03 Dec 20 at 10:39 AM in the 'BIOTECH' category. From Wed 18 Nov 20, the stock recorded 44.44% Up Days and 50.00% Green Days

The stock spiked on Mon 05 Oct 20 at $15 with a volume of 7M+, and its share price has been moving sideways in recent weeks.

About Enlivex Therapeutics Ltd. (ENLV:NASDAQ)

Bioblast Pharma Ltd is an Israel-based development-stage biopharmaceutical company. The firm is focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases. It focuses on therapeutic platforms that offer solutions for several diseases that share a common pathophysiological mechanism, which are the functional changes that accompany a particular syndrome or disease. It also focuses on diseases with severe and debilitating manifestations.